Navigation Links
Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
Date:11/2/2012

pies, and to evaluate the effects of the combination therapies on TG and other lipids and lipoproteins.

About Epanova™Epanova is a patent protected, novel, ultra-pure mixture of the free fatty acid forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Omthera has developed a substantial body of data on Epanova, which points to an improved and more predictable bioavailability as compared to the ethyl ester form found in prescription Omega-3 products currently available. Triglyceride lowering with Epanova was previously observed in two large, placebo-controlled, randomized, double-blind, Phase III studies involving 748 Crohn's disease patients with normal triglyceride levels for >/= 52 weeks, approximately 400 of which were treated with Epanova for remission of disease. In all studies performed to date, Epanova has demonstrated a very good safety and tolerability profile.

About HypertriglyceridemiaHypertriglyceridemia refers to a condition in which patients have high blood levels of triglycerides and is associated with increased risk of heart disease. It is one component of a range of lipid disorders collectively referred to as dyslipidemia. The overall dyslipidemia population in the U.S. is believed to be in excess of 100 million, with approximately 40 million of those diagnosed with hypertriglyceridemia (triglycerides greater than 200mg/dL) and an estimated 4 million with very high triglyceride levels (triglycerides greater than 500mg/dL). Very high triglycerides are associated with an increased risk of pancreatitis. Regulatory approval for the treatment of very high triglycerides is based on a significant reduction in the serum triglyceride levels.

About Omthera Pharmaceuticals, Inc.Founded in 2008, Omthera Pharmaceuticals, Inc. is a privately held, specialty pharmaceutical company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 31, 2015 The Allen Institute ... effort to define and advance the state-of-the-art digital ... launching today, called BigNeuron, aims to create reliable ... of branches that make up individual neurons: a ... encodes information. "In our quest ...
(Date:3/30/2015)... 2015 Shareholder rights attorneys at Robbins Arroyo ... Hyperion Therapeutics, Inc. (NASDAQ: HPTX ) by Horizon ... 2015, the two companies announced the signing of a ... Hyperion.  Under the terms of the agreement, Hyperion shareholders ... Hyperion common stock. View this information ...
(Date:3/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) will present ... 9:05 a.m. ET on Thursday, April 2, 2015, at the ... . Scott Foraker , vice president and general ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology:International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 2International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 4International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 5International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 6Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 2Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 3Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference 2
... Reportlinker.com announces that a new market research report ... Global Genetic Testing Industry ... markets for Genetic Testing in Millions of US$. The ... and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. ...
... 23, 2011 Reportlinker.com announces that a new ... Global Human Vaccines Industry ... This report analyzes the worldwide markets for Prophylatic ... segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines. ...
Cached Medicine Technology:Reportlinker Adds Global Genetic Testing Industry 2Reportlinker Adds Global Human Vaccines Industry 2
(Date:3/31/2015)... Lake, Wis. (PRWEB) March 31, 2015 ... their patients and a faster return on their investment, ... body composition analyzer at Obesity Medicine 2015, April 8-12 ... for busy weight loss centers and medical offices, Rice ... as a health assessment tool. Obesity Medicine 2015 delivers ...
(Date:3/31/2015)... Como, Italy (PRWEB) March 31, 2015 A' ... design project Food Feeder Plus by Justin Cheung has been ... in Baby, Kids' and Children's Products Design Competition ... project leader of the awarded Baby Products project Food Feeder ... to eat alone, but also means more independence for the ...
(Date:3/31/2015)... San Francisco, CA (PRWEB) March 31, 2015 ... provider of Population Health and Analytics solutions, announces the ... Sales. Bedenbaugh will work with the Senior Vice President ... transform healthcare by empowering primary care providers to create ... in the Northeast including New York, New Jersey, Connecticut, ...
(Date:3/31/2015)... March 31, 2015 A' Design Award ... project Bruker EVOQ by Daniel Dion has been announced ... in Scientific Instruments, Medical Devices and Research Equipment ... Dion, the creative mind behind the award winning Medical ... - developed under the direction of Dr. Rohan Thakur ...
(Date:3/31/2015)... Austin, TX (PRWEB) March 31, 2015 Mega ... fun photo app in the market today. This free app ... transforming them into artistically creative, exciting, and fun masterpieces. Mega ... with including twisting, morphing, pinching, warping, and spinning images in ... the game changers for Mega Photo is that it has ...
Breaking Medicine News(10 mins):Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2Health News:Justin Cheung wins Golden in A' International Baby Products Design Awards 2Health News:i2i Systems Announces the Hire of Robert Bedenbaugh 2Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:New Mega Photo App Launched and Provides the Ultimate Playground for Photos 2
... Scientists have discovered the first evidence linking brain function ... brain to size at birth and the weight of ... the causes of mental health problems in later life. ... and the Medical Research Council (MRC) Lifecourse Epidemiology Unit ...
... is associated with negative outcomes for the mother, including increased ... length of stay in the hospital, and does not provide ... deliveries continues to climb, it is important for physicians and ... The new findings, published in the February issue of ...
... , FRIDAY, Feb. 18 (HealthDay News) -- Doctors must not ... disorders who take antipsychotic drugs, experts warn. The authors of ... noted that patients with severe mental illness live an average ... disease, not suicide, is the major cause of death in these ...
... By Alan Mozes HealthDay Reporter , ... bike-only tracks that are physically separated from street traffic ... vehicles, a new study finds. "We found that ... bicycling on cycle tracks, compared with bicycling in parallel ...
... the basic functional concept is that synapses transmit electrical ... axons carry signals away (output). In one of many ... can operate in reverse: they can send signals to ... axons can talk to each other. Before sending signals ...
... Reinberg HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay News) ... the United States last fall, but is now circulating in all ... deaths from flu tripled in the past month, jumping from 10 ... U.S. Centers for Disease Control and Prevention. "We still have ...
Cached Medicine News:Health News:Brain function linked to birth size in groundbreaking new study 2Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 2Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 3Health News:Antipsychotic Drugs Raise Heart Risks, Experts Warn 2Health News:Separate Bikes-Only Lanes in Cities Cut Injury Rate: Study 2Health News:Separate Bikes-Only Lanes in Cities Cut Injury Rate: Study 3Health News:Rewrite the textbooks 2Health News:Rewrite the textbooks 3Health News:U.S. Flu Season Picking Up, CDC Reports 2
... an in-vitro diagnostic test kit for ... cruzi in human serum/plasma. This test ... using gelatin particles coated with inactivated ... particles are agglutinated in the presence ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
Inquire...
Silicone ICD lead...
Medicine Products: